Mark Schoenberg
Chief Tech/Sci/R&D Officer at UROGEN PHARMA LTD.
Net worth: 2 M $ as of 2024-03-30
Profile
Mark P.
Schoenberg is currently the Chief Medical Officer at UroGen Pharma Ltd.
He is also a Member of The American Association of Cancer Research, the Society of Urologic Nurses & Associates, and the Society of Urologic Oncology, Inc. Previously, he worked as a Professor at The Johns Hopkins University from 2005 to 2014 and as the Chief Medical Officer at Sonablate Corp.
Dr. Schoenberg completed his undergraduate degree at Yale University and his doctorate at the University of Texas Health Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
UROGEN PHARMA LTD.
0.41% | 2024-03-17 | 139,437 ( 0.41% ) | 2 M $ | 2024-03-30 |
Mark Schoenberg active positions
| Companies | Position | Start |
|---|---|---|
| UROGEN PHARMA LTD. | Chief Tech/Sci/R&D Officer | 2016-02-08 |
| The American Association of Cancer Research | Corporate Officer/Principal | - |
| Society of Urologic Oncology, Inc. | Corporate Officer/Principal | - |
Society of Urologic Nurses & Associates
 Society of Urologic Nurses & Associates Miscellaneous Commercial ServicesCommercial Services Society of Urologic Nurses & Associates operates as a nonprofit organization. The firm supports urologic health care professionals. It specializes in advancing urologic nursing practice and patient care. The company was founded in 1972 and is headquartered in Pitman, NJ. | Corporate Officer/Principal | - |
Former positions of Mark Schoenberg
| Companies | Position | End |
|---|---|---|
| The Johns Hopkins University | Corporate Officer/Principal | 2013-12-31 |
Sonablate Corp.
 Sonablate Corp. Medical SpecialtiesHealth Technology Sonablate Corp. develops and manufactures high intensity focused ultrasound surgical ablation systems. Its products include Sonablate 450, a HIFU solution that determines the safety and efficacy of a minimally invasive prostate cancer treatment; Sonablate 500, a HIFU surgical ablation system for the treatment of localized prostate cancer that delivers ablative therapy with the possibility of reducing side effects; and Sonatherm, a laparoscopic HIFU surgical ablation system that uses a laparoscopic probe to deliver robotic ablative therapy to soft tissue with a customizable ablation zone. The company was founded by Stephen R. Puckett Sr. and George M. Suarez in 2004 and is headquartered in Charlotte, NC. | Chief Tech/Sci/R&D Officer | - |
Training of Mark Schoenberg
| Yale University | Undergraduate Degree |
| University of Texas Health Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| UROGEN PHARMA LTD. | Health Technology |
| Private companies | 4 |
|---|---|
Society of Urologic Nurses & Associates
Society of Urologic Nurses & Associates Miscellaneous Commercial ServicesCommercial Services Society of Urologic Nurses & Associates operates as a nonprofit organization. The firm supports urologic health care professionals. It specializes in advancing urologic nursing practice and patient care. The company was founded in 1972 and is headquartered in Pitman, NJ. | Commercial Services |
Sonablate Corp.
Sonablate Corp. Medical SpecialtiesHealth Technology Sonablate Corp. develops and manufactures high intensity focused ultrasound surgical ablation systems. Its products include Sonablate 450, a HIFU solution that determines the safety and efficacy of a minimally invasive prostate cancer treatment; Sonablate 500, a HIFU surgical ablation system for the treatment of localized prostate cancer that delivers ablative therapy with the possibility of reducing side effects; and Sonatherm, a laparoscopic HIFU surgical ablation system that uses a laparoscopic probe to deliver robotic ablative therapy to soft tissue with a customizable ablation zone. The company was founded by Stephen R. Puckett Sr. and George M. Suarez in 2004 and is headquartered in Charlotte, NC. | Health Technology |
| The American Association of Cancer Research | |
| Society of Urologic Oncology, Inc. |
- Stock Market
- Insiders
- Mark Schoenberg
